McClung David 4
4 · BioCardia, Inc. · Filed Oct 11, 2022
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-10-10$2.07/sh+2,000$4,140→ 78,518 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades ranging from $2.06 to $2.08 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.